Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 8/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 7/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 6/20 | 0.39 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MAP3K5 | Q99683 | 1/20 | 0.32 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.32 |
| ▸ | PAK4 | O96013 | 1/20 | 0.32 |
| ▸ | CSF1R | P07333 | 1/20 | 0.32 |
| ▸ | RET | P07949 | 1/20 | 0.32 |
| ▸ | GRK5 | P34947 | 1/20 | 0.32 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.32 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.32 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.32 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.32 |
| ▸ | MAP4K2 | Q12851 | 1/20 | 0.32 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25068511 | 0.82 | PIK3CG (0.42) | PIK3CGPIK3CDPIK3CAPIK3CBTLR9 | |
| SCHEMBL16808004 | 0.79 | HSD17B10 (0.37) | TYRFYNMAP3K5DYRK1A | |
| SCHEMBL16781922 | 0.79 | AHR (0.38) | TYRFYNMAP3K5 | |
| SCHEMBL18727798 | 0.77 | PIK3CG (0.42) | PIK3CGPIK3CDPIK3CAPIK3CBNUDT1 | |
| SCHEMBL4325240 | 0.76 | PIK3CG (0.42) | PIK3CGPIK3CDPIK3CAPIK3CBNUDT1 | |
| SCHEMBL24656059 | 0.75 | PIK3CG (0.43) | PIK3CGPIK3CDPIK3CAPIK3CBNUDT1 | |
| Bromide SCHEMBL1260233 | 0.74 | PIK3CG (0.41) | PIK3CGPIK3CDPIK3CAPIK3CBNUDT1 | |
| SCHEMBL16781930 | 0.73 | FFAR1 (0.49) | FYNMAP3K5 | |
| SCHEMBL10044580 | 0.72 | PIK3CG (0.44) | PIK3CGPIK3CDPIK3CAPIK3CBNUDT1 | |
| SCHEMBL15415685 | 0.72 | AHR (0.51) | PIK3CGPIK3CDPIK3CAPIK3CBNUDT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250223286-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO.,LTD (CN) | 2025-07-10 | — | — | US | disclosed |
| US-12187713-B2 | Immunomodulators, compositions and methods thereof | BETTA PHARMACEUTICALS CO., LTD (CN) | 2025-01-07 | — | — | US | disclosed |
| US-20220098183-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO LTD (CN) | 2022-03-31 | — | — | US | disclosed |
| WO-2020156323-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | BETTA PHARMACEUTICALS CO., LTD (CN) | 2020-08-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250223286-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | IL2, IL5, TSLP | PIK3CG 2123/4885PIK3CD 2207/4885PIK3CA 2873/4885 |
| US-20220098183-A1 | IMMUNOMODULATORS, COMPOSITIONS AND METHODS THEREOF | IL2, TSLP, CD74 | PIK3CG 2009/4885PIK3CD 1907/4885PIK3CA 3087/4885 |
| US-12187713-B2 | Immunomodulators, compositions and methods thereof | IL2, TSLP, CD74 | PIK3CG 2009/4885PIK3CD 1907/4885PIK3CA 3087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.